Topgolf First to Open at the Pier Park City Center℠ Development in Panama City Beach, Florida
The two-level golf and entertainment venue opened on June 27, 2025 and is the tenth Topgolf location in Florida. The first Pier Park City Center business to open, Topgolf features 74 outdoor climate-controlled hitting bays along with a full-service restaurant and bar and year-round family-friendly programming.
'Topgolf will serve as an anchor for the Pier Park City Center development, helping to attract new businesses, spark additional investment and enhance the area's appeal as a dynamic hub for commercial opportunities,' said William Brock, St. Joe Vice President for Commercial Real Estate. 'Already a draw for the millions of visitors to Panama City Beach each year, the Pier Park shopping and entertainment district offers an ideal destination for new and established concepts looking to thrive in a high-traffic, high-growth environment.'
With plans for family-oriented entertainment concepts, the Pier Park City Center development spans approximately 80 acres in the popular Pier Park district, which currently includes more than one million square feet of retail and dining concepts as well as three hotels with a total of 500 rooms.
For more information about Topgolf Panama City Beach visit topgolf.com/us/panama-city-beach. To inquire about entertainment and commercial opportunities in the Pier Park City Center development, call 1.888.836.8353 or email lease@joe.com.
Important Notice Regarding Forward-Looking Statements
This press release contains 'forward-looking statements,' within the meaning of Section 21E of the Securities Exchange Act of 1934, including statements regarding the Pier Park City Center development, including those involving potential tenants, additional investment and future entertainment concepts. These forward-looking statements are qualified in their entirety by cautionary statements and risk factors set forth in St. Joe filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent current report filings, as well as the following: (1) the ability of St. Joe to complete Pier Park City Center development and (2) the interest of prospective tenants, customers and purchasers.
About The St. Joe Company
The St. Joe Company ('Company') is a diversified real estate development, asset management and operating company with real estate assets and operations in Northwest Florida. The Company intends to use existing assets for residential, hospitality and commercial ventures and has significant residential and commercial land-use entitlements. The Company actively seeks higher and better uses for its real estate assets through a range of development activities. More information about St. Joe can be found on its website at www.joe.com.
©2025 The St Joe Company. All Rights Reserved. 'St. Joe ®,' 'JOE ®,' the 'Taking Flight' Design ®,' 'St. Joe (and Taking Flight Design) ®,' 'Pier Park ®,' 'Pier Park City Center℠' and 'Pier Park City Center with sun/beachball design℠' are service marks of The St. Joe Company.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Abbott Laboratories (ABT): I Am Very Upset With Abbott,' Says Jim Cramer
We recently published . Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories (NYSE:ABT) is a healthcare company. While it was one of Cramer's top stocks for most of this year, this show saw the CNBC TV host take a different tone. Abbott Laboratories (NYSE:ABT)'s shares fell by 8.5% in July after the firm's latest earnings results saw it warn about a massive $1 billion hit in 2025 from tariffs. Here's what Cramer said about the firm: 'I am very upset with Abbott. They're on tonight. I have supported the company for years and years. It's the diagnostic business. We'll have Robert Ford on tonight, it's not catastrophic because I like the company, long term. But, this is not, this was another thing that happened this morning that I found quite disturbing. An operating room with a doctor monitoring a patient's vital signs during surgery with a medical device. Previously, Cramer discussed Abbott Laboratories (NYSE:ABT)'s earnings before the release: 'Then one of my absolute favorite companies, medical device maker, Abbott Labs reports. And you know, I always like to tell you which companies tend to be misinterpreted in a negative way during the earnings season. Abbott's a textbook example. It bothers me, but there are always sellers who claim to be disappointed. So, if you don't own any Abbott, may I suggest that you wait to see the numbers, wait for the stock's opening, wait for the sellers to appear. Patience is a virtue with ABT.' While we acknowledge the potential of ABT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 minutes ago
- Yahoo
Taiwan Semiconductor Manufacturing Company Limited (TSM): It's Good Because Of NVIDIA, Says Jim Cramer
We recently published . Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the stocks Jim Cramer recently discussed. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is the world's largest semiconductor contract manufacturer. Its shares, traded as depository receipts, have gained 21% year-to-date. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) has prospered on the stock market due to the firm's market share, which means that it will be the end-beneficiary of AI-chip demand. Cramer's previous comments about the firm have also called it a proxy for NVIDIA's shares. Here are his latest thoughts: [TSM]'Yeah look, Taiwan Semi reports overnight. It's an unbelievably good number but understand it's really unbelievably good number because of high performance computing. In other words, it's a good number because of NVIDIA. A close-up of a complex network of integrated circuits used in logic semiconductors. Previously, Cramer explained how Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) had gained the favor of the Trump administration: 'Look, I'd like them to do Taiwan Semi, I mean Taiwan Semi and NVIDIA, they're like the shovel ready and they go there, they pick, they watch tomorrow to see what state is the best and then they like go buy some shovels from Caterpillar and get to work. Yes! Yes! I mean I know it's not optics if it's Apple, but yes, they need to. And I don't care which part. But they need to. And I think that maybe they want to do what they think is great for shareholders, and this is a waste of money for shareholders but we have an aggressive administration. And Taiwan Semi went and put real money and I think that Apple is putting real money and somehow it's not visible.' While we acknowledge the potential of TSM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
14 minutes ago
- Yahoo
Elevance Health, Inc. (ELV): I Won't Touch It With A 10 Foot Pole, Says Jim Cramer
We recently published . Elevance Health, Inc. (NYSE:ELV) is one of the stocks Jim Cramer recently discussed. Elevance Health, Inc. (NYSE:ELV) is one of the biggest healthcare benefits companies in America. Its shares have dipped by 24% year-to-date, primarily on the back of a 19% dip in July. Elevance Health, Inc. (NYSE:ELV)'s shares fell after the firm cut its profit forecast to $30 per share from an earlier $34.15 to $34.85 per share. Here's what Cramer said about the firm: 'They missed. I think we're finally at the point where people have said, these guys are all going to keep going down so don't worry about it. Don't sell. That stock is down much less than I thought it would be. I'm not, I mean that. Like these ones, have been, when they go down, they don't just go down nine. But this thing has been down for a while. I wouldn't touch these stocks with a ten-foot pole. They're just, this is happening before they even eviscerated Medicaid. I don't think people realize that the thing in that beautiful bill was a huge gift to accelerated depreciation, a huge gift for R&D. And just a house of pain for anything Medicaid.' A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers. GreensKeeper Asset Management mentioned Elevance Health, Inc. (NYSE:ELV) in its Q1 2025 investor letter. Here is what the firm said: 'Rounding out our top 5 performers in Q1 were Elevance Health, Inc. (NYSE:ELV) +17.9% and Intercontinental Exchange (ICE) + 15.8%. As mentioned in the last Scorecard, we believe the sell-off in ELV over the past year has been overdone, and the stock is trading at a significant discount to our estimate of its intrinsic value. The recent rebound reflects a partial correction of that mispricing. ICE continues to perform well as a significant portion of its earnings is driven by transaction volume on its exchanges and increasing demand for financial data, both of which generally increase when panic-induced volatility hits the markets.' While we acknowledge the potential of ELV as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
